RRPV provides its members with opportunities to collaborate with key stakeholders, leverage access to key resources, and stay informed about government priorities. Learn more about how you can join the consortium.👇 hubs.la/Q03JF0ld0

RRPV is committed to accelerating partnerships, strengthening responsiveness, and addressing the growing demand for future medical countermeasure products. Learn more about how we are driving health security and innovation by visiting the link below. hubs.la/Q03JDZX_0

Join RRPV’s powerful network driving innovation in pandemic preparedness and response. Whether you’re a researcher, business leader, or policymaker, your expertise is vital to advancing resilient solutions for the future. Learn more: hubs.la/Q03Mn8Cd0 #RRPV

The RRPV Consortium is your pathway to groundbreaking projects driving innovation in the fight against biological threats. Stay ahead of the curve—check out our latest solicitations and see how you can help shape the future with bold new solutions.👇 hubs.la/Q03Mn8Dr0

Great to see consortium members Arizona State University and Applied Materials collaborating to advance innovation and shape the future of technology. Learn more about their new initiative below.

RRPV is at the forefront of driving breakthroughs in Medical Technology, Vaccines, Therapeutics, and Clinical Trial Solutions. See how your organization can play a pivotal role in these critical technology areas and learn more about the consortium.👇 hubs.la/Q03MnmHq0

RRPV Community: Make sure to join BARDA for its Innovation Summit on Nov. 20 in Washington, DC. Learn more and register for the event here: lnkd.in/eTgsxFDx #Event #Summit

🚨 Exciting news! Nearly $11 million in project funding was awarded to member True Diagnostics—advancing the Biothreat Diagnostic Rapid Response initiative to accelerate critical biothreat diagnostics. 🔗Learn more: bit.ly/42lzirN #RRPV #Innovation #Research

Joining RRPV means unlocking benefits to help your organization thrive: ✔️Exclusive access to networking opportunities, events, and trainings ✔️Insight into government priorities to align your MCM strategies Learn more and join today.👇 hubs.la/Q03Mnq2X0 #RRPV

We’ve updated our news page to include Member Spotlights! Check out the latest spotlights on Unicorn Biotechnologies and Sapphiros and learn more about how they’re driving innovation and impact across the field.👇 hubs.la/Q03PH3hP0 #RRPV #Members #Membership #Spotlight

In FY25, we proudly welcomed 182 new members to the RRPV Consortium! Check out our most up-to-date member list and see the incredible organizations working together to make an impact by visiting the link below. hubs.la/Q03Pv4Y20 #RRPV #Innovation #Collaboration

RRPV is seeking innovative, agnostic diagnostic technologies that can detect any viral or bacterial pathogen—including emerging threats. Abstracts are due Nov. 20, 2025, at 1 p.m. ET. Learn more below.👇 rrpv.org/solicitation/a…

RRPV has released an Request for Information for Rapid Antibody Development for Immunoassay Diagnostics (RAPID). Responses are due Thurs., Dec. 4 at 1 p.m. ET. Learn more and share your insights today.👇 rrpv.org/solicitation/r…

Together we’re building a healthier future! Join RRPV and help advance health security for the next pandemic or public health emergency. Learn how to join by visiting the link below. hubs.la/Q03R82fR0 #RRPV #Collaboration #HealthSecurity

RRPV unites a powerful network of innovators all working together to accelerate medical innovation. See which organizations are driving progress forward.👇 hubs.la/Q03R8bHM0 #RRPV #Membership #Members #Innovation

By connecting innovators and experts, RRPV is enhancing the ability to respond rapidly, collaborate strategically, and advance the next generation of medical countermeasures. Discover how.👇 hubs.la/Q03SB3HQ0 #RRPV #MCM #Collaboration

RRPV has released an RPP to advance immune assessment. The ASSURE program seeks innovative, high-throughput, sample-sparing assays to improve how we evaluate immune responses. Abstracts are due Dec. 18 at 1 p.m. ET. Learn more: bit.ly/4a419kC

Our key technology areas—Medical Technology, Vaccines, Therapeutics, and Clinical Trial Solutions—are designed to strengthen U.S. readiness, ensuring we can meet the evolving challenges of public health emergencies. Learn more.👇 hubs.la/Q03R87bv0 #RRPV

RRPV is an Other Transaction Agreement (OTA)-based vehicle focused on bringing cutting-edge research and technologies from industry directly to the federal government. Learn more about how the OTA model accelerates innovation by visiting the link below. hubs.la/Q03R84xd0

We've recently published two new member spotlights featuring PharmaJet and BRCR Global. Learn more about what unique capabilities they bring to the table, collaboration opportunities they’re actively seeking, and how you can connect today. Read more: hubs.la/Q03VtvVd0